iShares Genomics Immunology and Healthcare ETF
IDNA
103 hedge funds and large institutions have $115M invested in iShares Genomics Immunology and Healthcare ETF in 2021 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 34 increasing their positions, 22 reducing their positions, and 12 closing their positions.
117% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 12
55% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 22
16% more funds holding
Funds holding: 89 → 103 (+14)
11% more capital invested
Capital invested by funds: $104M → $115M (+$11.3M)
4.88% more ownership
Funds ownership: 27.7% → 32.59% (+4.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$5.88M |
| 2 |
Morgan Stanley
New York
|
+$5.33M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$3.72M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$2.38M |
| 5 |
AWM
Apollon Wealth Management
Mount Pleasant,
South Carolina
|
+$2.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$4.54M |
| 2 |
PWP
Principle Wealth Partners
Madison,
Connecticut
|
-$1.36M |
| 3 |
WBG
Wharton Business Group
Malvern,
Pennsylvania
|
-$1.08M |
| 4 |
FTUS
Flow Traders U.S.
New York
|
-$991K |
| 5 |
DAS
Dynamic Advisor Solutions
Phoenix,
Arizona
|
-$545K |
IDNA Hedge Fund Activity: Q4 2021 in Review
103 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in iShares Genomics Immunology and Healthcare ETF (IDNA) for Q4 2021, worth a combined $115M — up 11% from $104M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new IDNA positions and 12 closed out — a net gain of 14 holders — while 34 added to existing stakes and 22 trimmed.
The largest buyer was Jane Street, adding an estimated $5.88M. The largest seller was Bank of America, cutting an estimated $4.54M.
- 103 institutional investors held iShares Genomics Immunology and Healthcare ETF (IDNA) as of Q4 2021, up from 89 in Q3 2021.
- Funds reported $115M of iShares Genomics Immunology and Healthcare ETF stock for Q4 2021, up 11% quarter-over-quarter.
- 26 funds opened new iShares Genomics Immunology and Healthcare ETF positions in Q4 2021 and 12 closed out, a net change of +14 holders.
- The largest iShares Genomics Immunology and Healthcare ETF buyer in Q4 2021 was Jane Street, an estimated $5.88M added.
- The largest iShares Genomics Immunology and Healthcare ETF seller in Q4 2021 was Bank of America, an estimated $4.54M sold.
Based on aggregated 13F filings for Q4 2021.